The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition

著者: Sherene Loi, Stefan Michiels, Sylvia Adams, Sibylle Loibl, Jan Budczies, Carsten Denkert, Roberto Salgado - Annals of Oncology 2021 被引用: 271